Anifrolumab, a relatively emerging monoclonal antibody, is sparking considerable hope within the healthcare community as a potential solution for various immune-related ailments. This unique agent targets the https://bookmarklinking.com/story11469167/anifrolumab-a-promising-approach-for-autoimmune-illnesses